Home
Home
  Our FCA Practice The False Claims Act Submit Your Claim News 3rd Party Payers Contact Us
 

New False Claims and Complex Commercial Litigation Firm

Federal court unseals Baycol whistleblower complaint against Bayer

Team led by David Stone of BSF and the U.S. Government Settle $499 Million False Claims Act Case Against Bristol-Myers Squibb Company and Apothecon, Inc.

Team led by David Stone of BSF and the U.S. Government Settle $155 Million False Claims Act Case Against Medco Health Solutions

Taxpayers Against Fraud Conference
2005

Taxpayer’s Against Fraud Seminar-Recent Developments in the Law

Team led by David Stone of BSF joins government's False Claims Act case against Medco

October 14, 2004: David Stone addresses the annual convention of Taxpayers Against Fraud (TAF).
New False Claims and Complex Commercial Litigation Firm
Formed by David S. Stone and Robert A. Magnanini – Stone & Magnanini LLP
NEW FIRM WILL EXPAND SUCCESSFUL AND PROFITABLE QUI TAM PRACTICE

Short Hills, NJ, March 5, 2009 – David S. Stone and Robert A. Magnanini, former partners at Boies, Schiller & Flexner LLP, announced today that they have joined forces to create Stone & Magnanini LLP. The firm, with offices in New Jersey and New York, will be a national leader in plaintiff’s complex commercial litigation, including False Claims Act cases. Eric Jaso, former Justice Department official and federal prosecutor, will also join Stone & Magnanini in the position of counsel.

Stone and Magnanini bring extensive experience and proven expertise, spanning over twenty years, in False Claims Act cases and complex litigation matters. As the former head of Boies, Schiller & Flexner’s False Claims practice area, Stone’s accomplishments include recovering hundreds of millions of dollars for federal and state governments against healthcare giants Medco, Bristol Myers Squibb and Cephalon. Magnanini has been lead counsel in numerous cases prosecuting $100 million RICO claims, defending directors and officers, leading internal investigations, and removing organized crime influences from unions. Together, they successfully defended several clients in a recent U.S. Antitrust Division criminal investigation and civil class action arising out of alleged price-fixing in the market for luxury automobiles.

Moving forward, Stone & Magnanini will be prosecuting several significant False Claims Act cases, including a recently unsealed case against Forest Laboratories, Inc. for paying kickbacks and off-label marketing of the psychiatric drugs Lexapro and Celexa.

“We are excited about this opportunity to grow our profitable False Claims Act practice and to continue to build our complex litigation practice. Stone & Magnanini is well positioned to take on any case we believe has merit -- free of the conflicts inherent in larger firms representing institutional clients,” stated Stone in making the public announcement.

David Boies, Chairman of Boies, Schiller & Flexner, noted, “David and Bob were valued partners and are excellent lawyers. They are also entrepreneurs, and this new venture represents an opportunity to grow a False Claims Act practice with a proven track record.” Additionally, Boies stated, “Stone & Magnanini will be a first-rate law firm, and we will continue to work together on a number of substantial matters, including a lawsuit against Yahoo and AOL and on various cases arising out of the Bernie Madoff Ponzi scheme.”

In addition to its False Claims Acts practice, Stone & Magnanini will continue to represent clients in other complex litigations, including antitrust, securities, white collar criminal defenses, corporate compliance, internal investigations and appellate matters.
HOME I OUR FCA PRACTICE I THE FALSE CLAIMS ACT I SUBMIT YOUR CLAIM I NEWS I 3RD PARTY PAYERS I CONTACT US I DISCLAIMER I TOP

© 2009, Stone & Magnanini LLP. All rights reserved. Attorney advertising. Prior results do not guarantee a similar outcome.